Selected research
Industry Research
Atropine Sulfate API Industry Research Report 2026
Market perspective
The global Atropine Sulfate API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Atropine Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Atropine Sulfate API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Atropine Sulfate API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Atropine Sulfate API include Sichuan Ren An Pharmaceutical, Minsheng Group Shaoxing Pharmaceutical Co Ltd, Merck, China Resources Double-Crane Pharmaceutical, Henan Purui Pharmaceutical Co Ltd, Guangzhou Hanfang Pharmaceutical Company, Changzhou Kangpu Pharmaceutical, Saurav Chemicals Ltd and Rolabo Outsourcing Sl, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Atropine Sulfate API market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Atropine Sulfate API Market by Company
Sichuan Ren An Pharmaceutical
Minsheng Group Shaoxing Pharmaceutical Co Ltd
Merck
China Resources Double-Crane Pharmaceutical
Henan Purui Pharmaceutical Co Ltd
Guangzhou Hanfang Pharmaceutical Company
Changzhou Kangpu Pharmaceutical
Saurav Chemicals Ltd
Rolabo Outsourcing Sl
Resonance Laboratories Pvt Ltd
Pharmaffiliates Analytics and Synthetics
Hubei Biocause Heilen Pharmaceutical Co Ltd
Curia Wisconsin Inc
C-Squared Pharma Sarl
Alchem International Private Ltd
Atropine Sulfate API Segment by Type
Purity≥99%
Purity<99%
Atropine Sulfate API Segment by Application
Preparation of Therapeutic Drugs
Drug Research and Development
Others
Atropine Sulfate API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atropine Sulfate API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atropine Sulfate API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atropine Sulfate API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Atropine Sulfate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Atropine Sulfate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Atropine Sulfate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥99%
- Purity<99%
Applications
- Preparation of Therapeutic Drugs
- Drug Research and Development
- Others
Companies covered
- Sichuan Ren An Pharmaceutical
- Minsheng Group Shaoxing Pharmaceutical Co Ltd
- Merck
- China Resources Double-Crane Pharmaceutical
- Henan Purui Pharmaceutical Co Ltd
- Guangzhou Hanfang Pharmaceutical Company
- Changzhou Kangpu Pharmaceutical
- Saurav Chemicals Ltd
- Rolabo Outsourcing Sl
- Resonance Laboratories Pvt Ltd
- Pharmaffiliates Analytics and Synthetics
- Hubei Biocause Heilen Pharmaceutical Co Ltd
- Curia Wisconsin Inc
- C-Squared Pharma Sarl
- Alchem International Private Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Atropine Sulfate API Market Size (2021-2032)
- 2.2.2 Global Atropine Sulfate API Sales (2021-2032)
- 2.2.3 Global Atropine Sulfate API Market Average Price (2021-2032)
- 2.3 Atropine Sulfate API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity≥99%
- 2.3.3 Purity<99%
- 2.4 Atropine Sulfate API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Preparation of Therapeutic Drugs
- 2.4.3 Drug Research and Development
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Atropine Sulfate API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Atropine Sulfate API Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Atropine Sulfate API Revenue of Manufacturers (2021-2026)
- 3.4 Global Atropine Sulfate API Average Price by Manufacturers (2021-2026)
- 3.5 Global Atropine Sulfate API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Atropine Sulfate API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Atropine Sulfate API, Product Type & Application
- 3.8 Global Manufacturers of Atropine Sulfate API, Established Date
- 3.9 Global Atropine Sulfate API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sichuan Ren An Pharmaceutical
- 4.1.1 Sichuan Ren An Pharmaceutical Company Information
- 4.1.2 Sichuan Ren An Pharmaceutical Business Overview
- 4.1.3 Sichuan Ren An Pharmaceutical Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sichuan Ren An Pharmaceutical Atropine Sulfate API Product Portfolio
- 4.1.5 Sichuan Ren An Pharmaceutical Recent Developments
- 4.2 Minsheng Group Shaoxing Pharmaceutical Co Ltd
- 4.2.1 Minsheng Group Shaoxing Pharmaceutical Co Ltd Company Information
- 4.2.2 Minsheng Group Shaoxing Pharmaceutical Co Ltd Business Overview
- 4.2.3 Minsheng Group Shaoxing Pharmaceutical Co Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Minsheng Group Shaoxing Pharmaceutical Co Ltd Atropine Sulfate API Product Portfolio
- 4.2.5 Minsheng Group Shaoxing Pharmaceutical Co Ltd Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Atropine Sulfate API Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 China Resources Double-Crane Pharmaceutical
- 4.4.1 China Resources Double-Crane Pharmaceutical Company Information
- 4.4.2 China Resources Double-Crane Pharmaceutical Business Overview
- 4.4.3 China Resources Double-Crane Pharmaceutical Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 China Resources Double-Crane Pharmaceutical Atropine Sulfate API Product Portfolio
- 4.4.5 China Resources Double-Crane Pharmaceutical Recent Developments
- 4.5 Henan Purui Pharmaceutical Co Ltd
- 4.5.1 Henan Purui Pharmaceutical Co Ltd Company Information
- 4.5.2 Henan Purui Pharmaceutical Co Ltd Business Overview
- 4.5.3 Henan Purui Pharmaceutical Co Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Henan Purui Pharmaceutical Co Ltd Atropine Sulfate API Product Portfolio
- 4.5.5 Henan Purui Pharmaceutical Co Ltd Recent Developments
- 4.6 Guangzhou Hanfang Pharmaceutical Company
- 4.6.1 Guangzhou Hanfang Pharmaceutical Company Company Information
- 4.6.2 Guangzhou Hanfang Pharmaceutical Company Business Overview
- 4.6.3 Guangzhou Hanfang Pharmaceutical Company Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangzhou Hanfang Pharmaceutical Company Atropine Sulfate API Product Portfolio
- 4.6.5 Guangzhou Hanfang Pharmaceutical Company Recent Developments
- 4.7 Changzhou Kangpu Pharmaceutical
- 4.7.1 Changzhou Kangpu Pharmaceutical Company Information
- 4.7.2 Changzhou Kangpu Pharmaceutical Business Overview
- 4.7.3 Changzhou Kangpu Pharmaceutical Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Changzhou Kangpu Pharmaceutical Atropine Sulfate API Product Portfolio
- 4.7.5 Changzhou Kangpu Pharmaceutical Recent Developments
- 4.8 Saurav Chemicals Ltd
- 4.8.1 Saurav Chemicals Ltd Company Information
- 4.8.2 Saurav Chemicals Ltd Business Overview
- 4.8.3 Saurav Chemicals Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Saurav Chemicals Ltd Atropine Sulfate API Product Portfolio
- 4.8.5 Saurav Chemicals Ltd Recent Developments
- 4.9 Rolabo Outsourcing Sl
- 4.9.1 Rolabo Outsourcing Sl Company Information
- 4.9.2 Rolabo Outsourcing Sl Business Overview
- 4.9.3 Rolabo Outsourcing Sl Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Rolabo Outsourcing Sl Atropine Sulfate API Product Portfolio
- 4.9.5 Rolabo Outsourcing Sl Recent Developments
- 4.10 Resonance Laboratories Pvt Ltd
- 4.10.1 Resonance Laboratories Pvt Ltd Company Information
- 4.10.2 Resonance Laboratories Pvt Ltd Business Overview
- 4.10.3 Resonance Laboratories Pvt Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Resonance Laboratories Pvt Ltd Atropine Sulfate API Product Portfolio
- 4.10.5 Resonance Laboratories Pvt Ltd Recent Developments
- 4.11 Pharmaffiliates Analytics and Synthetics
- 4.11.1 Pharmaffiliates Analytics and Synthetics Company Information
- 4.11.2 Pharmaffiliates Analytics and Synthetics Business Overview
- 4.11.3 Pharmaffiliates Analytics and Synthetics Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Pharmaffiliates Analytics and Synthetics Atropine Sulfate API Product Portfolio
- 4.11.5 Pharmaffiliates Analytics and Synthetics Recent Developments
- 4.12 Hubei Biocause Heilen Pharmaceutical Co Ltd
- 4.12.1 Hubei Biocause Heilen Pharmaceutical Co Ltd Company Information
- 4.12.2 Hubei Biocause Heilen Pharmaceutical Co Ltd Business Overview
- 4.12.3 Hubei Biocause Heilen Pharmaceutical Co Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hubei Biocause Heilen Pharmaceutical Co Ltd Atropine Sulfate API Product Portfolio
- 4.12.5 Hubei Biocause Heilen Pharmaceutical Co Ltd Recent Developments
- 4.13 Curia Wisconsin Inc
- 4.13.1 Curia Wisconsin Inc Company Information
- 4.13.2 Curia Wisconsin Inc Business Overview
- 4.13.3 Curia Wisconsin Inc Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Curia Wisconsin Inc Atropine Sulfate API Product Portfolio
- 4.13.5 Curia Wisconsin Inc Recent Developments
- 4.14 C-Squared Pharma Sarl
- 4.14.1 C-Squared Pharma Sarl Company Information
- 4.14.2 C-Squared Pharma Sarl Business Overview
- 4.14.3 C-Squared Pharma Sarl Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 C-Squared Pharma Sarl Atropine Sulfate API Product Portfolio
- 4.14.5 C-Squared Pharma Sarl Recent Developments
- 4.15 Alchem International Private Ltd
- 4.15.1 Alchem International Private Ltd Company Information
- 4.15.2 Alchem International Private Ltd Business Overview
- 4.15.3 Alchem International Private Ltd Atropine Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Alchem International Private Ltd Atropine Sulfate API Product Portfolio
- 4.15.5 Alchem International Private Ltd Recent Developments
5 Global Atropine Sulfate API Market Scenario by Region
- 5.1 Global Atropine Sulfate API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Atropine Sulfate API Sales by Region: 2021-2032
- 5.2.1 Global Atropine Sulfate API Sales by Region: 2021-2026
- 5.2.2 Global Atropine Sulfate API Sales by Region: 2027-2032
- 5.3 Global Atropine Sulfate API Revenue by Region: 2021-2032
- 5.3.1 Global Atropine Sulfate API Revenue by Region: 2021-2026
- 5.3.2 Global Atropine Sulfate API Revenue by Region: 2027-2032
- 5.4 North America Atropine Sulfate API Market Facts & Figures by Country
- 5.4.1 North America Atropine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Atropine Sulfate API Sales by Country (2021-2032)
- 5.4.3 North America Atropine Sulfate API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Atropine Sulfate API Market Facts & Figures by Country
- 5.5.1 Europe Atropine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Atropine Sulfate API Sales by Country (2021-2032)
- 5.5.3 Europe Atropine Sulfate API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Atropine Sulfate API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Atropine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Atropine Sulfate API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Atropine Sulfate API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Atropine Sulfate API Market Facts & Figures by Country
- 5.7.1 South America Atropine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Atropine Sulfate API Sales by Country (2021-2032)
- 5.7.3 South America Atropine Sulfate API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Atropine Sulfate API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Atropine Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Atropine Sulfate API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Atropine Sulfate API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Atropine Sulfate API Sales by Type (2021-2032)
- 6.1.1 Global Atropine Sulfate API Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Atropine Sulfate API Sales Market Share by Type (2021-2032)
- 6.2 Global Atropine Sulfate API Revenue by Type (2021-2032)
- 6.2.1 Global Atropine Sulfate API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Atropine Sulfate API Revenue Market Share by Type (2021-2032)
- 6.3 Global Atropine Sulfate API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Atropine Sulfate API Sales by Application (2021-2032)
- 7.1.1 Global Atropine Sulfate API Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Atropine Sulfate API Sales Market Share by Application (2021-2032)
- 7.2 Global Atropine Sulfate API Revenue by Application (2021-2032)
- 7.2.1 Global Atropine Sulfate API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Atropine Sulfate API Revenue Market Share by Application (2021-2032)
- 7.3 Global Atropine Sulfate API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Atropine Sulfate API Value Chain Analysis
- 8.1.1 Atropine Sulfate API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Atropine Sulfate API Production Mode & Process
- 8.2 Atropine Sulfate API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Atropine Sulfate API Distributors
- 8.2.3 Atropine Sulfate API Customers
9 Global Atropine Sulfate API Analyzing Market Dynamics
- 9.1 Atropine Sulfate API Industry Trends
- 9.2 Atropine Sulfate API Industry Drivers
- 9.3 Atropine Sulfate API Industry Opportunities and Challenges
- 9.4 Atropine Sulfate API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst